Summary

Eureka Therapeutics Inc

Founded in 2006

Description

Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T cells for the treatment of solid tumors and other mal...

Strengths

  • Eureka Therapeutics Inc has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Demonstrating revenue growth that is faster than the industry average
  • The number of employees is growing faster than the industry average
  • Since Eureka Therapeutics Inc was founded, the company has grown faster than the industry average
  • Web traffic rankings are better than the industry average

Weaknesses

  • Variance of revenue growth is more than the industry average

Annual Revenue

Eureka Therapeutics Inc's annual revenue

$40000000

Based on Kona Equity data

  • Revenue per employee

    $784314

  • Variance of revenue growth

    5.23

  • Annual revenue growth since founding

    $2222222

  • Revenue growth rate from first known quarter to current

    334.8%

Employee Count

51 employees

  • Employee growth rate from first known quarter to current

    67.4%

G Score - 6

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G7 Website traffic rankings are better than the industry average

Web Analysis

  • Rank

    2.26 M

  • Page views per visitor

    2.0

  • Daily time

    1:46

Location

5858 HORTON St. Ste. 362 
Emeryville, CA  94608

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

TScan Therapeutics

tscan.com
  • Founded in 2018
  • Location: Waltham, MA
  • Annual Revenue: $11.1M
  • Employees: 104
  • TScan Therapeutics is a clinical stage biopharmaceutical company that is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.

Harpoon Therapeutics

harpoontx.com
  • Founded in 2015
  • Location: South San Francisco, CA
  • Annual Revenue: $20.6M
  • Employees: 104
  • Harpoon Therapeutics is an immuno oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases. Harpoon has created a novel antibody-based d...

Tmunity Therapeutics

tmunity.com
  • Founded in 2015
  • Location: Philadelphia, PA
  • Annual Revenue: $50.2M
  • Employees: 40
  • Tmunity Therapeutics is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), universal engineered T cell platforms, and Chimeric Antigen....

Tcr2 Therapeutics

tcr2.com
  • Founded in 2017
  • Location: Cambridge, MA
  • Annual Revenue: $29.0M
  • Employees: 137
  • TCR is an immunotherapy company developing the next generation of T cell therapies for patients suffering from cancer.

NexImmune Inc

neximmune.com
  • Founded in 2009
  • Location: Gaithersburg, MD
  • Annual Revenue: $7.4M
  • Employees: 22
  • Neximmune is a clinical stage biotech company that develops unique T cell immunotherapies for cancer, autoimmune, and infectious diseases. They utilize their proprietary AIM nanoparticle technology to create synthetic dendritic cells that direct a spec...

Checkmate Pharmaceuticals Inc.

checkmatepharma.com
  • Founded in 2015
  • Location: Cambridge, MA
  • Annual Revenue: $10.1M
  • Employees: 30
  • Empowering the immune system to beat back cancer

Key Information

  • SIC: 28; 283
  • NAICS: 32541; 5417
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Eureka Therapeutics Inc.

See similar companies

Frequently Asked Questions

Where is Eureka Therapeutics Inc located?

Eureka Therapeutics Inc's headquarters are located at 5858 HORTON St. Ste. 362  Emeryville, CA  94608.


What is Eureka Therapeutics Inc's official website?

Eureka Therapeutics Inc's official website is eurekatherapeutics.com


What is Eureka Therapeutics Inc's revenue?

Eureka Therapeutics Inc's annual revenue is $40.0 M.


What is Eureka Therapeutics Inc's SIC code?

Eureka Therapeutics Inc's SIC: 28; 283


What is Eureka Therapeutics Inc's NAICS code?

Eureka Therapeutics Inc's NAICS: 32541; 5417.


How many employees does Eureka Therapeutics Inc's have?

Eureka Therapeutics Inc has 51 employees


What industry does Eureka Therapeutics Inc belong to?

Eureka Therapeutics Inc is in the industry of Biotechnology.

Next step

Visitors review